Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
Status:
Terminated
Trial end date:
2017-05-25
Target enrollment:
Participant gender:
Summary
Patients who have undergone the Fontan procedure (a congenital heart surgery) may develop
complications many years after their operation. Studies have shown that some of these
patients develop an ongoing inflammatory state, which may be the cause of these late
complications. Aspirin is a common over the counter anti-inflammatory medication used for
many other chronic diseases. This study may help determine if aspirin therapy can limit the
inflammation seen in Fontan patients and prevent these late complications.